Health Populi
JULY 11, 2019
This research organization will develop medicines targeting older adults — which makes sense because Clover Health’s target consumer market is Medicare Advantage beneficiaries. The objective of this investment round is to further scale GNS solutions that personalize medicines to individual patients.
Health Populi
MAY 20, 2021
Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. to approve Medicare’s negotiation of drug prices with pharmaceutical companies].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT News - Telehealth
DECEMBER 16, 2020
” For this report, PwC’s Health Research Institute surveyed 2,511 American consumers, 128 health plan executives, 153 healthcare provider organization executives, and 124 pharmaceutical and life sciences executives in August and September 2020. ” the report read. “Quite a bit, it turns out.
Health Populi
MAY 14, 2018
Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement. Incentives for lowering list prices for medicines, such as FDA requiring that drug companies include list prices in ads and bringing more transparency to Medicare drug pricing and generic competition, and.
Health Populi
OCTOBER 28, 2019
The bar chart shows that PhRMA (the advocacy group for the pharmaceutical industry), Blue Cross & Blue Shield Association, the American Hospital Association, and the American Medical Association (representing physicians) were four of the ten highest spending lobbyers in 2018. A recent study on politics and health care spending in the U.S.
Health Populi
MARCH 19, 2019
Payors have begun to recognize the value of nudging consumers toward over-the-counter products under Medicare Advantage plans. To that point, IRI’s Kristin Hornberger presented new data on retail health market performance in 2018. Consumer health as a category was $45 billion in 2018, growing at 2.1%.
Insulin Nation
AUGUST 22, 2016
If so, this would lead to Medicare-contracted insurance plans covering the cost of CGMs as reimbursable durable medical equipment. If the CGM becomes covered by Medicare, demand for CGMs could spike even further. (While many CGM users already do this, it is not technically an allowed use for the device, according to FDA labeling.).
Expert insights. Personalized for you.
220 
Let's personalize your content